Pharmafile Logo

Amici Procurement Solutions

Amici provide cutting edge sourcing solutions to companies across the Biotech industry. Our business is to deliver greater savings through improved supplier performance. We can support you whether you are looking for an outsourced procurement resource or simply to save money quickly. We offer consortium deals, consultancy, training and a virtual purchasing resource. Uniquely, we also provide a savings guarantee.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

3 Centura Court, Nasmyth Place, Glasgow, G52 4PR
+44 (0)141 810 2580

 Latest Content from PMHub 

Your Lucid Group Guide to us!

Check out our Lucid Story We are a global healthcare consultancy. We deliver life-transforming value through pioneering solutions that change behaviour, improve clinical practice and advance health outcomes. People are...

Planning for 2022?

Reach key healthcare practitioners in Infectious Disease, Aesthetic Surgery, Cardiology, Neuro-Oncology, Gerontology, Gastroenterology and more

Six ways to improve diversity in clinical trials

Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...

Four wins coveted position on government roster £500m government campaign roster partners announced

28 September 2021: Four Communications has been successful in gaining a coveted position on the main integrated UK government roster for the next four years – achieving the ability to...

Accelerating Revenue Cycle Performance in the Healthcare Industry

Videos and Podcasts | November 11, 2021 | Impetus Digital

Michael Duke, Principal Healthcare Consultant at Baker Tilly US, discusses the importance of data and analytics for internal audits, organizational risk reduction, workflow automation, and to drive value in healthcare....

How femtech is changing the future of women’s health

Press Releases | November 11, 2021 | Thrive Agency

The femtech industry has the potential to be the next stage of evolution in the open access movement. Taking on the role of a public library, which allows a wider...

Revolutionising the Digital Content Delivery Model

White Papers and Resources | November 11, 2021 | M3 (EU)

Pharmaceutical industry processes don’t have to make the delivery of marketing campaigns slow and unmanageable, and thus ineffective. Changing working practices and really, truly thinking differently about how to deliver...

Fishawack Health welcomes expert-led dermatology initiative FIDE to its group

Press Releases | November 10, 2021 | Avalere Health

Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology

Opening up about patient engagement

Read the third blog of the series looking at key barriers to effective patient engagement in pharma

Rethinking immunodermatology: Patient and market insights from leading KOLs and life science leaders

In our new publication, we speak to key opinion leaders and industry experts to uncover novel strategies for commercializing immunodermatology therapies in a crowded market landscape.